Avalon Pharmaceuticals to Present at BIO CEO & Investor Conference
February 10 2006 - 1:10PM
PR Newswire (US)
GERMANTOWN, Md., Feb. 10 /PRNewswire-FirstCall/ -- Avalon
Pharmaceuticals, Inc. (Nasdaq and ArcaEx(R): AVRX), a
biopharmaceutical company focused on the discovery and development
of small molecule therapeutics, today announced that Kenneth C.
Carter, Ph.D., President and CEO and Gary Lessing, Executive Vice
President and CFO are scheduled to present and participate in panel
discussions at the Eighth Annual BIO CEO & Investor Conference,
being held February 14-15, 2006 at the Waldorf-Astoria Hotel in New
York. On Tuesday, February 14th, Dr. Carter will provide a
corporate overview and discuss the company's recent progress at
3:30 pm EST. This presentation will be webcast live and will be
accessible through Avalon's website at http://www.avalonrx.com/,
under Investor Relations / Upcoming Presentations. An archive of
the presentation will be available for 90 days following the
presentation. Also on February 14th at 4:00 pm EST, Mr. Lessing
will participate in a business roundtable panel discussion entitled
"Finance/Regulatory: Sarbanes-Oxley Blues -- Impact of Section 404
and Prescription for Reform". On Wednesday, February 15th at 3:30
pm EST, Dr. Carter will participate in a focus session panel
discussion entitled "Genomics: Genomics is Back". An archive of the
panel session will be available on the BIO CEO website
(http://ceo.bio.org/opencms/ceo/2006/index.jsp) by Thursday
February 16th. About Avalon Pharmaceuticals Avalon Pharmaceuticals
is a biopharmaceutical company focused on the discovery and
development of small molecule therapeutics for the treatment of
cancer. Avalon seeks to discover and develop novel therapeutics
through the use of a comprehensive, innovative and proprietary
suite of technologies based upon large-scale gene expression
analysis which it calls AvalonRx(R). Avalon Pharmaceuticals was
established in 1999 and is headquartered in Germantown, Maryland.
Contacts: Avalon Pharmaceuticals, Inc. Noonan Russo Gary Lessing
Wendy Lau (Media) Executive Vice President and CFO Tel: (212)
845-4272 Tel: (301) 556-9900 Fax: (301) 556-9910 Jane Petrino
(Investors) Email: Tel: (212) 845-4274 DATASOURCE: Avalon
Pharmaceuticals, Inc. CONTACT: Gary Lessing, Executive Vice
President and CFO of Avalon Pharmaceuticals, Inc., +1-301-556-9900,
Fax: +1-301-556-9910, ; or Media - Wendy Lau, +1-212-845-4272, or
Investors - Jane Petrino, +1-212-845-4274, both of Noonan Russo Web
site: http://www.avalonrx.com/
http://ceo.bio.org/opencms/ceo/2006/index.jsp
Copyright